Although IgA antibodies are unable to activate the classical complement pathway, recent insights suggest antibodies and IgA particularly may be implicated in the activation of the alternative and lectinic complement pathway in lupus glomeruli [27]. This evidence concerns the gene CD79A and systemic lupus erythematosus.